CME Group Statistics
Total Valuation
CME Group has a market cap or net worth of BRL 533.90 billion. The enterprise value is 540.26 billion.
| Market Cap | 533.90B |
| Enterprise Value | 540.26B |
Important Dates
The next estimated earnings date is Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | Sep 8, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.12% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.30% |
| Owned by Institutions (%) | 89.85% |
| Float | 359.02M |
Valuation Ratios
The trailing PE ratio is 26.95 and the forward PE ratio is 24.94.
| PE Ratio | 26.95 |
| Forward PE | 24.94 |
| PS Ratio | 15.69 |
| PB Ratio | 3.55 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 24.53 |
| P/OCF Ratio | 24.08 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.84, with an EV/FCF ratio of 24.82.
| EV / Earnings | 27.27 |
| EV / Sales | 15.98 |
| EV / EBITDA | 20.84 |
| EV / EBIT | 22.49 |
| EV / FCF | 24.82 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.83 |
| Debt / FCF | 0.92 |
| Interest Coverage | 24.43 |
Financial Efficiency
Return on equity (ROE) is 13.35% and return on invested capital (ROIC) is 8.13%.
| Return on Equity (ROE) | 13.35% |
| Return on Assets (ROA) | 1.60% |
| Return on Invested Capital (ROIC) | 8.13% |
| Return on Capital Employed (ROCE) | 11.08% |
| Revenue Per Employee | 9.05M |
| Profits Per Employee | 5.27M |
| Employee Count | 3,760 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CME Group has paid 5.78 billion in taxes.
| Income Tax | 5.78B |
| Effective Tax Rate | 22.37% |
Stock Price Statistics
The stock price has increased by +15.38% in the last 52 weeks. The beta is 0.30, so CME Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +15.38% |
| 50-Day Moving Average | 374.56 |
| 200-Day Moving Average | 320.44 |
| Relative Strength Index (RSI) | 52.37 |
| Average Volume (20 Days) | 63 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.22 |
Income Statement
In the last 12 months, CME Group had revenue of BRL 34.03 billion and earned 19.81 billion in profits. Earnings per share was 55.00.
| Revenue | 34.03B |
| Gross Profit | 34.03B |
| Operating Income | 22.18B |
| Pretax Income | 25.84B |
| Net Income | 19.81B |
| EBITDA | 23.95B |
| EBIT | 22.18B |
| Earnings Per Share (EPS) | 55.00 |
Balance Sheet
The company has 13.70 billion in cash and 20.09 billion in debt, giving a net cash position of -6.39 billion.
| Cash & Cash Equivalents | 13.70B |
| Total Debt | 20.09B |
| Net Cash | -6.39B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 150.24B |
| Book Value Per Share | 417.50 |
| Working Capital | 17.13B |
Cash Flow
In the last 12 months, operating cash flow was 22.18 billion and capital expenditures -411.43 million, giving a free cash flow of 21.76 billion.
| Operating Cash Flow | 22.18B |
| Capital Expenditures | -411.43M |
| Free Cash Flow | 21.76B |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 65.19% and 58.95%.
| Gross Margin | 100.00% |
| Operating Margin | 65.19% |
| Pretax Margin | 75.94% |
| Profit Margin | 58.95% |
| EBITDA Margin | 70.38% |
| EBIT Margin | 65.19% |
| FCF Margin | 63.96% |
Dividends & Yields
This stock pays an annual dividend of 10.66, which amounts to a dividend yield of 2.88%.
| Dividend Per Share | 10.66 |
| Dividend Yield | 2.88% |
| Dividend Growth (YoY) | 27.21% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 103.53% |
| Buyback Yield | -0.12% |
| Shareholder Yield | 2.76% |
| Earnings Yield | 3.71% |
| FCF Yield | 4.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CME Group has an Altman Z-Score of 0.52 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.52 |
| Piotroski F-Score | 4 |